Samsara Therapeutics unveils promising autophagy drug candidate, offering new hope for people with Parkinson’s and motor neurone disease

Cleara Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medical Officer and Head of Clinical Development

Paul Scherrer Institute and Apollo Health Ventures Launch Focal Biosciences

Cleara Biotech Raises $2.5 Million in Seed Financing to Advance FOXO4-Therapeutics Pipeline for Treating Cancer and Chronic Diseases

Auron Therapeutics Announces $48 Million Series A Financing to drive novel oncology pipeline leveraging a machine learning, multi-omics based platform

Haya Therapeutics, backed by Apollo since March 2021, listed among Europe's top biotech investments

Haya Therapeutics raises Seed extension round and expands to San Diego

Apollo Health Ventures Closes $180 Million Fund to Drive Breakthrough Innovations Combating Age-related Diseases